deferoxamine has been researched along with Graft Occlusion, Vascular in 1 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angel, MF | 1 |
| Mellow, CG | 1 |
| Knight, KR | 1 |
| O'Brien, BM | 1 |
1 other study available for deferoxamine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
The effect of deferoxamine on tolerance to secondary ischaemia caused by venous obstruction.
Topics: Animals; Deferoxamine; Graft Occlusion, Vascular; Male; Rats; Rats, Inbred Strains; Reperfusion Inju | 1989 |